Technegas® for COPD
Chronic Obstructive Pulmonary Disease
Phase 2Active
Key Facts
About Cyclomedica
Global leader in nuclear pulmonary imaging with Technegas® for diagnosis and management of respiratory diseases.
View full company profileTherapeutic Areas
Other Chronic Obstructive Pulmonary Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Emeramide for COPD | EmeraMed | Phase 2 |
| Autologous Stem Cell Therapy for COPD | STEMGENICS | Phase 2 |
| Meridigen‑COPD | Meridigen Biotech | Preclinical |
| Novel Anti-inflammatory for COPD | Shenzhen Salubris Pharmaceuticals | Phase I/II |
| F528 | Gyre Therapeutics | Not Specified |